A1RG34:BVMF
Argenx Se Bdr
187,38 R$
arrow_upward
+1,99%(+3,65) 1D
6 қаз., 16:56:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1RG34...
Open
187,38 R$
High
187,38 R$
Low
187,38 R$
Mkt. cap
58,45 млрд
Avg. vol.
57,00
Volume
0,00
52-wk high
213,15 R$
52-wk low
143,22 R$
Shares outstanding
62,56 млн
No. of employees
2 мың
Open
187,38 R$
High
187,38 R$
Low
187,38 R$
Mkt. cap
58,45 млрд
Avg. vol.
57,00
Volume
0,00
52-wk high
213,15 R$
52-wk low
143,22 R$
Shares outstanding
62,56 млн
No. of employees
2 мың
News stories
From web sources and news partners
Investing.com Canada
·
2 сағат бұрын
Halozyme expands argenx collaboration with two new targets By Investing.com
Yahoo Finance
·
3 сағат бұрын
Halozyme Announces Expansion of Global Collaboration and License Agreement with argenx to Support the Development of Subcutaneous Formulations for Two Additional Exclusive Targets Using its ENHANZE® Technology
AD HOC NEWS
·
6 сағат бұрын
argenx stock: New VYVGART data span myasthenia gravis and CIDP
AD HOC NEWS
·
1 күн бұрын
Argenx stock gets fresh VYVGART data before Q3 results
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About Argenx Se Bdr